BPG is committed to discovery and dissemination of knowledge
Citation
Savaliya BP, Shekouhi R, Mubarak F, Manaise HK, Jimenez PB, Kowkabany G, Popp RA, Popp K, Gabriel E. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors. World J Gastroenterol 2024; 30(24): 3052-3058 [PMID: 38983963 DOI: 10.3748/wjg.v30.i24.3052]
Please LOGIN to submit a new comment.